Use of povidone-iodine in the treatment of presumptive adenoviral conjunctivitis

Annals of Ophthalmology - Glaucoma

Volumn 30, Issue 6, 1998, Pages 341-343

  Abel Jr , Robert ^a,b   Abel, Ari D ^c  

^a Concord Plaza Naamans Bldg ^*  (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c GREATER BALTIMORE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

POVIDONE IODINE;

ADENOVIRUS; ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; KERATOCONJUNCTIVITIS; MALE; PRIORITY JOURNAL; TOPICAL DRUG ADMINISTRATION; VIRUS INFECTION; VISUAL ACUITY;

EID: 0344541981     PISSN: 10794794     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Speaker MG, Menikoff JA. Prophylaxis of endophthalmitis with topical povidone-iodine. Ophthalmology. 1991;98:1769-1775.
2. Isenberg SJ, Apt L, Yoshimori R, Khwarg S. Chemical preparation of the eye in ophthalmic surgery: comparison of povidone-iodine on the conjunctiva with a prophylactic antibiotic. Arch Ophthalmol. 1985;103:1340-1342.
3. Apt L, Isenberg SJ, Yoshimori R, et al. The effect of povidone-iodine ophthalmic solution applied at the conclusion of ophthalmic surgery. Am J Ophthalmol. 1995;119:701-705.
4. Isenberg SJ, Apt L, Yoshimori R, Pham C, Lam NIC. Efficacy of topical povidone-iodine during the first week after ophthalmic surgery. Am J Ophthalmol. 1997;124:31-35.
5. Benevento WJ, Murray P, Reed CA, Pepose JS. The sensitivity of Neisseria gonorrhoeae, Chlamydia trachomatis, and herpes simplex type 2 to disinfection with povidone-iodine. Am J Ophthalmol. 1990;109:329-333.
6. Harbison MA, Hammer SM. Inactivation of human immunodeficiency virus by Betadine products and chlorhexidine. J Acquir Immune Defic Syndr. 1989;2:16-20.
7. Kaplan JC, Crawford DC, Durno AG, Schooley RT. Inactivation of human immunodeficiency virus by Betadine. Infect Control. 1987; 8:412-414.
8. Asanaka M, Kurimura T. Inactivation of human immunodeficiency virus (HIV) by povidone-iodine. Acta Med Yonago. 1987;30:89-92.
9. Kono R, Yoshii T. The effect of iodine to disinfect herpes virus, adenovirus type 8, and AHC virus. J Jpn Ophthalmol Assoc. 1978; 49:267-271.
10. Lund E. Oxidative inactivation of different types of enteroviruses. Am J Hyg. 1964;80:1.
11. Klein M, DeForest A. The inactivation of viruses by germicides. Proceedings of the 49th Mid-Year Meeting of Chemical Specialties Manufacturers Assoc. 1973:116.
12. Plotkin SA. The effect of povidone-iodine on several viruses. In: Ehrenkranz NJ, Polk HC, eds. Therapeutic Advances and New Clinical Implications: Medical and Surgical Antisepsis with Betadine Microbicides. Yonkers, NY: Purdue Frederick Co.; 1972:9-16.
13. Pernicky J. (Personal experience with the use of Betadine gtt. in the treatment of epidemic viral keratoconjunctivitis.) Ceskoslovenska Oftalmologie. 1994;50(5):323-324.
14. Mac Rae SM, Brown B, Edelhauser HE The corneal toxicity of presurgical skin antiseptics. Am J Ophthalmol. 1984;97:221-232.
15. Berkelman RL, Lewin S, Allen JR, et al. Pseudobacteremia attributed to contamination of povidone-iodine with Pseudomonas cepacia. Ann Intern Med. 1981;95:32.
16. Craven DE, Moody B, Connolly MG, Kollisch NR, Stottmeier KG, McCabe WR. Pseudobacteremia caused by povidone-iodine solution contaminated with Pseudomonas cepacia. N Engl J Med. 1981; 305:621.
17. Berkelman RL, Holland BW, Anderson RL. Increased bactericidal activity of dilute preparations of povidone-iodine solutions. J Clin Microbiol. 1982;15:635.
18. Houang ET, Gilmore OJA, Reid L, Shaw EJ. Absence of bacterial resistance to povidone-iodine. J Clin Pathol. 1976;29:752-755.